Evaluation of HepaGam B [hepatitis-B-immune-globulin] in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2013
At a glance
- Drugs Hepatitis B immune globulin (Primary) ; Adefovir dipivoxil; Antivirals; Lamivudine
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Cangene Corporation
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2013 Planned end date changed from 1 Jan 2014 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 17 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.